The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


0.18%w/v Sodium Chloride and 4.0% w/v Glucose Intravenous Infusion BP, (Viaflo Container)

0.18/4 percent weight/volume Solution for infusion

Baxter Holding B.V.PA2299/008/005

Main Information

Trade Name0.18%w/v Sodium Chloride and 4.0% w/v Glucose Intravenous Infusion BP, (Viaflo Container)
Active SubstancesSodium chloride
Anhydrous glucose
Strength0.18/4 percent weight/volume
Dosage FormSolution for infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/008/005

Group Information

ATC CodeB05XA Electrolyte solutions
B05XA31 electrolytes in combination with other drugs

Status

Authorised/WithdrawnAuthorised
Licence Issued24/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back